Susceptibility of Clostridium difficile strains to new antibiotics: quinolones, efrotomycin, teicoplanin and imipenem.
Newsom
S W
SW
Matthews
J
J
Rampling
A M
AM
D002939:Ciprofloxacin; D003013:Clostridium / Q000187:drug effects*; D006020:Glycopeptides / Q000494:pharmacology; D015378:Imipenem; D008826:Microbial Sensitivity Tests; D011728:Pyridones / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D017334:Teicoplanin; D013845:Thienamycins / Q000494:pharmacology; D014640:Vancomycin / Q000494:pharmacology
D006020:Glycopeptides; D011728:Pyridones; D011804:Quinolines; D013845:Thienamycins; C012954:efrotomycin; D002939:Ciprofloxacin; D017334:Teicoplanin; D014640:Vancomycin; D015378:Imipenem